Abstract
本研究目的在探討初次靜脈化療之婦癌患者副作用狀況。採時間序列性研究設計,以立意取樣的方式,選擇初次接受三個住院化療療程之婦癌患者為研究對象,自民國89年10月至民國90年5月共收得有效樣本23位。結果顯示三次化學治療療程期間的副作用頻率以疲倦、掉頭髮、噁心嘔吐、食慾不振、味覺改變及失眠最多。副作用嚴重度方面則以掉頭髮、失眠、食慾不振、發燒∕白血球降低及便秘較高。三次化學治療期間,各副作用的發生頻率並無顯著差異。但是第一個療程副作用的嚴重度顯著大於第三個療程(p=0.039),第三個療程中,接受VIP療程者的副作用頻率(Mean=9.75)顯著多於Cisplantin加其他藥物之療程者(Mean=6.08)(p<.05)。研究結果可提供護理人員,照顧及指導初次化療之婦癌患者副作用及其自我照顧的參考。
The purposes of this study were to explore the side effects for Gynecological cancer patients who received the initial chemotherapy. Time-series research design was adopted as guide for this study. Purpose sampling was used to select subjects who met inclusion criteria. A total of 23 patients were selected from October 2000 to May 2001. The-missing rate was 18%. The results indicated: The highest occurrence of side effects in three courses of chemotherapy was: fatigue, alopecia, nausea/vomiting, decreased appetite, taste changes, and sleeping difficulty. The most severe side effect was stated as follow: alopecia, sleeping difficulty, decreased appetite, fever/neutropenia, and constipation. The occurrence of side effects was no significant in three courses of chemotherapy. The severeness of the side effects in the first-therapy was higher than third-therapy (p=0.039). The frequency of side effects of VIP regimen (Mean=9.75) was more than Cisplantin adding other chemotherapy medicines (Mean=6.08) (p<.05) in the third-therapy. These findings provide guidance to providers the health care providers to promote quality of care by educating self-care activities for these Gynecological cancer patients who received their initial chemotherapy.
The purposes of this study were to explore the side effects for Gynecological cancer patients who received the initial chemotherapy. Time-series research design was adopted as guide for this study. Purpose sampling was used to select subjects who met inclusion criteria. A total of 23 patients were selected from October 2000 to May 2001. The-missing rate was 18%. The results indicated: The highest occurrence of side effects in three courses of chemotherapy was: fatigue, alopecia, nausea/vomiting, decreased appetite, taste changes, and sleeping difficulty. The most severe side effect was stated as follow: alopecia, sleeping difficulty, decreased appetite, fever/neutropenia, and constipation. The occurrence of side effects was no significant in three courses of chemotherapy. The severeness of the side effects in the first-therapy was higher than third-therapy (p=0.039). The frequency of side effects of VIP regimen (Mean=9.75) was more than Cisplantin adding other chemotherapy medicines (Mean=6.08) (p<.05) in the third-therapy. These findings provide guidance to providers the health care providers to promote quality of care by educating self-care activities for these Gynecological cancer patients who received their initial chemotherapy.
Original language | Chinese (Traditional) |
---|---|
Pages (from-to) | 29-43 |
Journal | 腫瘤護理雜誌 |
Volume | 2 |
Issue number | 1 |
State | Published - 2002 |